Consistent with these findings, high levels of MRPL42 are associated with tumour recurrence in breast cancer patients and are predictive of distant metastasis in estrogen-receptor negative basal breast cancer [24, 46], as shown in Table 2. Here, MRPL42 is linked to neoplasm.